A carregar...
Narrowing the gap: access to HIV treatments in developing countries. A pharmaceutical company's perspective
The advent of new antiretroviral medicines means that the effects of HIV can now be curbed, but only one in twenty infected people have so far benefited. For those living in developing countries, the new treatments are practically unattainable. Governments, UNAIDS and pharmaceutical companies recogn...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Group
2000
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1733177/ https://ncbi.nlm.nih.gov/pubmed/10701172 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jme.26.1.47 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|